Cargando…

Monoclonal Antibodies as Neurological Therapeutics

Over the last 30 years the role of monoclonal antibodies in therapeutics has increased enormously, revolutionizing treatment in most medical specialties, including neurology. Monoclonal antibodies are key therapeutic agents for several neurological conditions with diverse pathophysiological mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gklinos, Panagiotis, Papadopoulou, Miranta, Stanulovic, Vid, Mitsikostas, Dimos D., Papadopoulos, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912592/ https://www.ncbi.nlm.nih.gov/pubmed/33530460 http://dx.doi.org/10.3390/ph14020092

Ejemplares similares

The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
por: Gklinos, Panagiotis, et al.
Publicado: (2021)

Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials
por: Gklinos, Panagiotis, et al.
Publicado: (2020)

Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide
por: Gklinos, Panagiotis, et al.
Publicado: (2023)

Neurological manifestations of COVID-19: a review of what we know so far
por: Gklinos, Panagiotis
Publicado: (2020)

Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far?
por: Mavridis, Theodoros, et al.
Publicado: (2021)

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Nocebo in Biosimilars and Generics in Neurology: A Systematic Review
por: Spanou, Ioanna, et al.
Publicado: (2019)

The Evolving Role of Microsampling in Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory Diseases
por: Mingas, Panagiotis-Dimitrios, et al.
Publicado: (2021)

Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases
por: LaHue, Sara C., et al.
Publicado: (2020)

Neuropathic Pain in Neurologic Disorders: A Narrative Review
por: Mitsikostas, Dimos-Dimitrios, et al.
Publicado: (2022)

Therapeutic Applications of Monoclonal Antibodies
por: Berger, Mitchell, et al.
Publicado: (2002)

Aging, Cellular Senescence, and Progressive Multiple Sclerosis
por: Papadopoulos, Dimitrios, et al.
Publicado: (2020)

Cluster headache: a quasi-rare disorder needing a reappraisal
por: Martelletti, Paolo, et al.
Publicado: (2015)

New players in the preventive treatment of migraine
por: Mitsikostas, Dimos D., et al.
Publicado: (2015)

Treating primary headaches – management of migraine
por: Mitsikostas, Dimos D
Publicado: (2013)

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine
por: Vikelis, Michail, et al.
Publicado: (2012)

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
por: Gogesch, Patricia, et al.
Publicado: (2021)

Monoclonal Antibodies and Invasive Aspergillosis: Diagnostic and Therapeutic Perspectives
por: Lian, Xihua, et al.
Publicado: (2022)

Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
por: Ormundo, Leonardo F., et al.
Publicado: (2023)

Therapeutic monoclonal antibody for sporotrichosis
por: Almeida, Sandro R.
Publicado: (2012)

A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study
por: Mitsikostas, Dimos D., et al.
Publicado: (2021)

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma
por: Bonello, Francesca, et al.
Publicado: (2019)

Recent progress in the molecular imaging of therapeutic monoclonal antibodies
por: He, Kaifeng, et al.
Publicado: (2020)

Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings
por: Germovsek, Eva, et al.
Publicado: (2021)

How mRNA therapeutics are entering the monoclonal antibody field
por: Van Hoecke, Lien, et al.
Publicado: (2019)

Human monoclonal antibodies as candidate therapeutics against emerging viruses
por: Jin, Yujia, et al.
Publicado: (2017)

Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies
por: Briani, Chiara, et al.
Publicado: (2022)

Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies
por: Moni, Sivakumar S., et al.
Publicado: (2022)

Refractory Headache: One Term does Not cover All – A Statement of the European Headache Federation
por: Lampl, Christian, et al.
Publicado: (2014)

Therapeutic Monoclonal Antibodies and Emergence of Their Biosimilars
por: Jeddi-Tehrani, Mahmood
Publicado: (2018)

The pharmacology and therapeutic applications of monoclonal antibodies
por: Castelli, María Sofía, et al.
Publicado: (2019)

Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
por: Martelletti, Paolo, et al.
Publicado: (2014)

Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19
por: Chen, Junsen, et al.
Publicado: (2021)

A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19
por: Asdaq, Syed Mohammed Basheeruddin, et al.
Publicado: (2021)

Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon
por: Manti, Sara, et al.
Publicado: (2021)

The Therapeutic Value of Monoclonal Antibodies Directed Against Immunogenic Tumor Glycoproteins
por: Arlen, Myron, et al.
Publicado: (2010)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
por: Gravbrot, Nicholas, et al.
Publicado: (2019)

Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging
por: Effer, Brian, et al.
Publicado: (2023)

The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
por: Castillo, Jorge J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e72u0g6s770q84obffcm7rluu9